Dynamics of the early immune cellular reactions after myogenic cell transplantation

Cell Transplantation

Volumn 11, Issue 7, 2002, Pages 671-681

  Skuk, Daniel ^a   Caron, Nicolas ^a   Goulet, Marlyne ^a   Roy, Brigitte ^a   Espinosa, Francisco ^a   Tremblay, Jacques P ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

CD4+ lymphocyte; CD8+ lymphocyte; Macrophage; Myoblast; Natural killer cell; Neutrophil

Indexed keywords

ANIMAL CELL; ARTICLE; CELL IMMORTALIZATION; CELL INFILTRATION; CELL INVASION; CELL POPULATION; CELL SURVIVAL; CELL TRANSPLANTATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DYNAMICS; FEMALE; MACROPHAGE; MALE; MOUSE; MUSCLE CELL; MYOBLAST; NATURAL KILLER CELL; NEUTROPHIL; NEWBORN; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 0036914209     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000002783985378     Document Type: Article

References (38)

1. Beauchamp, J. R.; Morgan, J. E.; Pagel, C. N.; Partridge, T. A. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J. Cell Biol. 144:1113-22; 1999.
2. Beauchamp, J. R.; Morgan, J. E.; Pagel, C. N.; Partridge, T. A. Quantitative studies of efficacy of myoblast transplantation. Muscle Nerve S261; 1994.
3. Beauchamp, J. R.; Pagel, C. N.; Partridge, T. A. A dual-marker system for quantitative studies of myoblast transplantation in the mouse. Transplantation 63:1794-1797; 1997.
4. Caron, N. J.; Chapdelaine, P.; Tremblay, J. P. Male-specific competitive PCR for the quantification of transplanted cells in mice. Biotechniques 27:424-426, 428; 1999.
5. Day, C. S.; Kasemkijwattana, C.; Menetrey, J.; Floyd, S. S., Jr.; Booth, D.; Moreland, M. S.; Fu, F. H.; Huard, J. Myoblast-mediated gene transfer to the joint. J. Orthop. Res. 15:894-903; 1997.
6. Deglon, N.; Heyd, B.; Tan, S. A.; Joseph, J. M.; Zurn, A. D.; Aebischer, P. Central nervous system delivery of recombinant ciliary neurotrophic factor by polymer encapsulated differentiated C2C12 myoblasts. Hum. Gene Ther. 7:2135-2146; 1996.
7. Dhawan, J.; Pan, L. C.; Pavlath, G. K.; Travis, M. A.; Lanctot, A. M.; Blau, H. M. Systemic delivery of human growth hormone by injection of genetically engineered myoblasts. Science 254:1509-1512; 1991.
8. El Fahime, E.; Torrente, Y.; Caron, N. J.; Bresolin, M. D.; Tremblay, J. P. In vivo migration of transplanted myoblasts requires matrix metalloproteinase activity. Exp. Cell Res. 258:279-287; 2000.
9. Guerette, B.; Asselin, I.; Skuk, D.; Entman, M.; Tremblay, J. P. Control of inflammatory damage by anti-LFA-1: Increase success of myoblast transplantation. Cell Transplant. 6:101-107; 1997.
10. Guerette, B.; Skuk, D.; Celestin, F.; Huard, C.; Tardif, F.; Asselin, I.; Roy, B.; Goulet, M.; Roy, R.; Entman, M.; Tremblay, J. P. Prevention by anti-LFA-1 of acute myoblast death following transplantation. J. Immunol. 159:2522-2531; 1997.
11. Hamamori, Y.; Samal, B.; Tian, J.; Kedes, L. Myoblast transfer of human erythropoietin gene in a mouse model of renal failure. J. Clin. Invest. 95:1808-1813; 1995.
12. Hodgetts, S. I.; Beilharz, M. W.; Scalzo, A. A.; Grounds, M. D. Why do cultured transplanted myoblasts die in vivo? DNA quantification shows enhanced survival of donor male myoblasts in host mice depleted of CD4+ and CD8+ cells or Nk1.1+ cells. Cell Transplant. 9:489-502; 2000.
13. Hofmann, A.; Blau, H. M. Death of solid tumor cells induced by Fas ligand expressing primary myoblasts. Somat. Cell Mol. Genet. 23:249-257; 1997.
14. Hohlfeld, R.; Engel, A. G. Lysis of myotubes by alloreactive cytotoxic T cells and natural killer cells. Relevance to myoblast transplantation. J. Clin. Invest. 86:370-374; 1990.
15. Huard, J.; Acsadi, G.; Jani, A.; Massie, B.; Karpati, G. Gene transfer into skeletal muscles by isogenic myoblasts. Hum. Gene Ther. 5:949-958; 1994.
16. MacPherson, G. G.; Christmas, S. E. The role of the macrophage in cardiac allograft rejection in the rat. Immunol. Rev. 77:143-166; 1984.
17. Manilay, J. O.; Sykes, M. Natural killer cells and their role in graft rejection. Curr. Opin. Immunol. 10:532-538; 1998.
18. Merly, F.; Huard, C.; Asselin, I.; Robbins, P. D.; Tremblay, J. P. Anti-inflammatory effect of transforming growth factor-betal in myoblast transplantation. Transplantation 65:793-799; 1998.
19. Merly, F.; Lescaudron, L.; Rouaud, T.; Crossin, F.; Gardahaut, M. F. Macrophages enhance muscle satellite cell proliferation and delay their differentiation. Muscle Nerve 22:724-732; 1999.
20. Moisset, P. A.; Bonham, L.; Skuk, D.; Koeberl, D.; Brussee, V.; Goulet, M.; Roy, B.; Asselin, I.; Miller, A. D.; Tremblay, J. P. Systemic production of human granulocyte colony-stimulating factor in nonhuman primates by transplantation of genetically modified myoblasts. Hum. Gene Ther. 11:1277-1288; 2000.
21. Morgan, J. E.; Beauchamp, J. R.; Pagel, C. N.; Peckham, M.; Ataliotis, P.; Jat, P. S.; Noble, M. D.; Farmer, K.; Partridge, T.A. Myogenic cell lines derived from transgenic mice carrying a thermolabile T antigen: A model system for the derivation of tissue-specific and mutationspecific cell lines. Dev. Biol. 162:486-498; 1994.
22. Orimo, S.; Hiyamuta, E.; Arahata, K.; Sugita, H. Analysis of inflammatory cells and complement C3 in bupivacaine-induced myonecrosis. Muscle Nerve 14:515-520; 1991.
23. Papadimitriou, J. M.; Robertson, T. A.; Mitchell, C. A.; Grounds, M. D. The process of new plasmalemma formation in focally injured skeletal muscle fibers. J. Struct. Biol. 103:124-134; 1990.
24. Pimorady-Esfahani, A.; Grounds, M. D.; McMenamin, P. G. Macrophages and dendritic cells in normal and regenerating murine skeletal muscle. Muscle Nerve 20:158-166; 1997.
25. Qu, Z.; Balkir, L.; van Deutekom, J. C.; Robbins, P. D.; Pruchnic, R.; Huard, J. Development of approaches to improve cell survival in myoblast transfer therapy. J. Cell Biol. 142:1257-1267; 1998.
26. Rando, T. A.; Pavlath, G. K.; Blau, H. M. The fate of myoblasts following transplantation into mature muscle. Exp. Cell Res. 220:383-389; 1995.
27. Reinlib, L.; Field, L. Cell transplantation as future therapy for cardiovascular disease?: A workshop of the National Heart, Lung, and Blood Institute. Circulation 101:E182-187; 2000.
28. Robertson, T. A.; Maley, M. A.; Grounds, M.; Papadimitriou, J. M. The role of macrophages in skeletal muscle regeneration with particular reference to chemotaxis. Exp. Cell Res. 207:321-331; 1993.
29. Round, J. M.; Jones, D. A.; Cambridge, G. Cellular infiltrates in human skeletal muscle: Exercise induced damage as a model for inflammatory muscle disease? J. Neurol. Sci. 82:1-11; 1987.
30. Simonson, G. D.; Groskreutz, D. J.; Gorman, C. M.; MacDonald, M. J. Synthesis and processing of genetically modified human proinsulin by rat myoblast primary cultures. Hum. Gene Ther. 7:71-78; 1996.
31. Skuk, D.; Tremblay, J. P. Complement deposition and cell death after myoblast transplantation. Cell Transplant. 7:427-434; 1998.
32. Skuk, D.; Tremblay, J. P. Progress in myoblast transplantation: A potential treatment of dystrophies. Microsc. Res. Tech. 48:213-222; 2000.
33. Smythe, G. M.; Hodgetts, S. I.; Grounds, M. D. Immunobiology and the future of myoblast transfer therapy. Mol. Ther. 1:304-313; 2000.
34. Tidball, J. G. Inflammatory cell response to acute muscle injury. Med. Sci. Sports Exerc. 27:1022-1032; 1995.
35. Torrente, Y.; El Fahime, E.; Caron, N. J.; Bresolin, N.; Tremblay, J. P. Intramuscular migration of myoblasts transplanted after muscle pretreatment with metalloproteinases. Cell Transplant. 9:539-549; 2000.
36. Tremblay, J. P.; Guérette, B. Myoblast transplantation: A brief review of the problems and of some solutions. Basic Appl. Myol. 7: 1997.
37. Wang, J. M.; Zheng, H.; Blaivas, M.; Kurachi, K. Persis-C tent systemic production of human factor IX in mice by skeletal myoblast-mediated gene transfer: Feasibility of repeat application to obtain therapeutic levels. Blood 90: 1075-1082; 1997.
38. Yamamoto, N.; Einaga-Naito, K.; Kuriyama, M.; Kawada, Y.; Yoshida, R. Cellular basis of skin allograft rejection in mice: Specific lysis of allogeneic skin components by non-T cells. Transplantation 65:818-825; 1998.